Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.72% | 52.85 | 0.9% | $1374.69m | |
| JNJ | Johnson & Johnson | 1.40% | 179.46 | 0.7% | $1371.52m | |
| BMY | Bristol-Myers Squibb Co. | 0.63% | 76.67 | 1.0% | $1204.82m | |
| MRK | Merck & Co., Inc. | 0.45% | 93.98 | 0.7% | $1144.89m | |
| ABBV | AbbVie, Inc. | -1.98% | 148.02 | 1.9% | $1115.58m | |
| LLY | Eli Lilly & Co. | 1.25% | 302.57 | 1.1% | $903.32m | |
| AZN | AstraZeneca Plc | 0.30% | 66.41 | 1.0% | $519.21m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.66% | 142.97 | 0.0% | $461.53m | |
| VERU | Veru, Inc. | 5.53% | 14.12 | 0.0% | $336.28m | |
| NVS | Novartis AG | 1.45% | 90.72 | 0.2% | $254.85m | |
| GSK | GlaxoSmithKline Plc | 0.53% | 44.76 | 0.2% | $244.47m | |
| HZNP | Horizon Therapeutics Plc | -3.29% | 87.38 | 5.4% | $193.81m | |
| NVO | Novo Nordisk A/S | 0.07% | 107.83 | 0.1% | $190.87m | |
| SGEN | Seagen Inc. | -0.22% | 139.34 | 5.7% | $181.36m | |
| VTRS | Viatris, Inc. | -1.44% | 11.63 | 0.0% | $163.74m |
Company Profile
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.